Verrica Pharmaceuticals (VRCA) Receivables (2022 - 2025)
Historic Receivables for Verrica Pharmaceuticals (VRCA) over the last 4 years, with Q3 2025 value amounting to $7.0 million.
- Verrica Pharmaceuticals' Receivables rose 828928.57% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 828928.57%. This contributed to the annual value of $77000.0 for FY2024, which is 9825.63% down from last year.
- According to the latest figures from Q3 2025, Verrica Pharmaceuticals' Receivables is $7.0 million, which was up 828928.57% from $9.2 million recorded in Q2 2025.
- Verrica Pharmaceuticals' 5-year Receivables high stood at $10.2 million for Q2 2024, and its period low was $77000.0 during Q4 2024.
- Its 4-year average for Receivables is $4.8 million, with a median of $5.0 million in 2023.
- In the last 5 years, Verrica Pharmaceuticals' Receivables plummeted by 9825.63% in 2024 and then surged by 828928.57% in 2025.
- Verrica Pharmaceuticals' Receivables (Quarter) stood at $99000.0 in 2022, then skyrocketed by 4360.61% to $4.4 million in 2023, then plummeted by 98.26% to $77000.0 in 2024, then surged by 9051.95% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $9.2 million for Q2 2025, and $5.7 million during Q1 2025.